Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma.

Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2019 10 01; 25(19):5787-5798.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Combined Modality Therapy
Female
GPI-Linked Proteins
Humans
Listeria monocytogenes
Lung Neoplasms
Male
Mesothelioma
Middle Aged
Pemetrexed
Pleural Neoplasms
Survival Rate
Tumor Microenvironment

authors with profiles

Hedy Kindler